Evidence map›Paper›PMID 34362468›Full record

ArticleTropical medicine and health2021

Initial presenting symptoms, comorbidities and severity of COVID-19 patients during the second wave of epidemic in Myanmar.

Ye Minn Htun, Tun Tun Win, Aung Aung, Thant Zin Latt, Yan Naung Phyo, Thet Min Tun, Nyan Sint Htun, Kyaw Myo Tun, Khin Aung Htun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Characteristics of Oral Adverse Effects following COVID-19 Vaccination and Similarities with Oral Symptoms in COVID-19 Patients: Taste and Saliva Secretory Disorders.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ye Minn HtunDepartment of Prevention and Research Development of Hepatitis, AIDS and Other Viral Diseases, Health and Disease Control Unit, Nay Pyi Taw, 15011, Myanmar. dryeminnhtun85@gmail.com.ORCID http://orcid.org/0000-0002-9706-9834
Tun Tun WinDepartment of Preventive and Social Medicine, Defence Services Medical Academy, Mingalardon, Yangon, Myanmar.ORCID https://orcid.org/0000-0001-9353-9766
Aung AungDepartment of Research and Development, Defence Services Medical School, Hmawbi, Yangon, Myanmar.ORCID https://orcid.org/0000-0001-9799-9225
Thant Zin LattDepartment of Research and Development, Defence Services Medical School, Hmawbi, Yangon, Myanmar.
Yan Naung PhyoOutpatient Department, No. 3 Military Hospital (100 Bedded), Hlegu, Yangon, Myanmar.
Thet Min TunDepartment of Preventive and Social Medicine, Defence Services Medical Academy, Mingalardon, Yangon, Myanmar.ORCID https://orcid.org/0000-0001-7720-7104
Nyan Sint HtunDepartment of Preventive and Social Medicine, Defence Services Medical Academy, Mingalardon, Yangon, Myanmar.ORCID https://orcid.org/0000-0003-3114-1511
Kyaw Myo TunDepartment of Preventive and Social Medicine, Defence Services Medical Academy, Mingalardon, Yangon, Myanmar.ORCID https://orcid.org/0000-0003-1211-1034
Khin Aung HtunDepartment of Surgery, Defence Services Medical Academy, Mingalardon, Yangon, Myanmar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) caused by a highly contagious virus called severe acute respiratory syndrome coronavirus 2 emerged in China at the end of 2019 and became a major threat to health around the world. The health experts are still learning more about the detailed knowledge of the natural course and the severity of COVID-19. The study aimed to assess the prevalence and association of severity of disease with demographic characteristics, initial presenting symptoms, and comorbidities among COVID-19 patients in treatment centers, Myanmar.

methodsA cross-sectional study was conducted at Hmawbi and Indine treatment centers, Yangon Region, Myanmar, from November to December 2020. Data were collected by using standardized case report forms and then, a total of 222 confirmed COVID-19 inpatients were included in this study. The odds ratio with a 95% confidence interval (CI) was used as a measure of association and the independent associated factors for severity of disease were investigated using logistic regression analysis.

resultsIn total, 81.5% were symptomatic patients and of these, the most common presenting symptoms were fever 54.1%, loss of smell 50.3%, and cough 30.9%. Among 37.8% of COVID-19 patients with comorbidities, the most common comorbidities were hypertension 58.3%, diabetes mellitus 29.8%, and heart diseases 26.2%, respectively. As a severity, 20.7% of patients had signs of severe pneumonia. The associated factors of severe pneumonia were aged 60 years and older [Adjusted odds ratio (AOR) = 2.88, 95% CI 1.14-7.29], overweight or obesity (AOR: 3.87, 95%CI 1.80-8.33), and current smoking (AOR: 6.74, 95% CI 2.72-16.75).

conclusionsIn this study, one-fifth of the patients developed severe pneumonia. The COVID-19 patients who were aged 60 years and older, overweight or obesity, and current smokers should be monitored carefully during the course of treatment to reduce the disease severity.

Indexed as

ComorbiditiesCOVID-19Initial presenting symptomsPneumoniaSeverity

Identifiers

PMID34362468
PMCPMC8343344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.